| Item Type | Name |
|
Concept
|
Psychiatric Status Rating Scales
|
|
Concept
|
Wechsler Scales
|
|
Concept
|
Security Measures
|
|
Academic Article
|
A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.
|
|
Academic Article
|
Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial.
|
|
Academic Article
|
Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.
|
|
Academic Article
|
Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy.
|
|
Academic Article
|
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
|
|
Academic Article
|
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
|
|
Academic Article
|
Premorbid functioning and treatment response in recent-onset schizophrenia.
|
|
Academic Article
|
Perceived patient threat and neuroleptic dosage.
|
|
Academic Article
|
Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?
|
|
Academic Article
|
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
|
|
Academic Article
|
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
|
|
Academic Article
|
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
|
|
Academic Article
|
Assessment of dementia in elderly schizophrenics with structured rating scales.
|
|
Academic Article
|
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
|
|
Academic Article
|
Leukotomy and aging in chronic schizophrenia: a followup study 40 years after psychosurgery.
|
|
Academic Article
|
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study.
|
|
Academic Article
|
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
|
|
Academic Article
|
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients.
|
|
Academic Article
|
Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders.
|
|
Academic Article
|
Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment.
|
|
Academic Article
|
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
|
|
Academic Article
|
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms.
|
|
Academic Article
|
Serotonin function and treatment response to clozapine in schizophrenic patients.
|
|
Academic Article
|
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
|
|
Academic Article
|
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
|
|
Academic Article
|
Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder.
|
|
Academic Article
|
Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew.
|
|
Academic Article
|
Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance.
|
|
Academic Article
|
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
|
|
Academic Article
|
Age-related differences in formal thought disorder in chronically hospitalized schizophrenic patients: a cross-sectional study across nine decades.
|
|
Academic Article
|
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
|
|
Academic Article
|
Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).
|
|
Academic Article
|
Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.
|
|
Academic Article
|
The association between adaptive and cognitive deficits in geriatric chronic schizophrenic patients.
|
|
Academic Article
|
Symptom severity and cognitive impairment in chronically hospitalised geriatric patients with affective disorders.
|
|
Academic Article
|
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
|
|
Academic Article
|
Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients.
|
|
Academic Article
|
Verbal fluency deficits in geriatric and nongeriatric chronic schizophrenic patients.
|
|
Academic Article
|
Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.
|
|
Academic Article
|
Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
|
|
Academic Article
|
Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
|
|
Academic Article
|
Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
|
|
Academic Article
|
The puzzle of processing speed, memory, and executive function impairments in schizophrenia: fitting the pieces together.
|
|
Academic Article
|
Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.
|
|
Academic Article
|
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
|
|
Academic Article
|
Risk of completed suicide in 89,049 young males assessed by a mental health professional.
|
|
Academic Article
|
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
|
|
Academic Article
|
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial.
|
|
Academic Article
|
The brief negative symptom scale (BNSS): Sensitivity to treatment effects.
|
|
Academic Article
|
Validation of a Hebrew selective reminding test.
|
|
Concept
|
Patient Reported Outcome Measures
|